| | |
ASPsiRNA information |
siRNA Id: | aspsirna0860
|
siRNA Name: | ShR-P14
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | GUCGGCACUUGUUACAGGU
|
ASP-siRNA (As strand 3'->5'): | GUCGGUACUUGUUACAGGU
|
Mismatch position in siRNA: | U14C |
Gene Information |
Gene Name | Ataxin-7(ATXN7) |
Target Sequence (5'->3'): | AGGUUGCCAAAGUGCCAGCCGUGAACAAUGUCCACAUGA
|
Wild allele (5'->3'): | CAGCCGUGAACAAUGUCCA
|
Mutant allele (5'->3'): | CAGCCAUGAACAAUGUCCA
|
Position of siRNA on target gene: | 3132-3150
|
Respective Gene/Protein Resources |
GenBank Accession: | NM000333.3 |
Cytogenic location: | 3p14.1 |
Chromosomal coordinates: | 3:63,849,784-63,989,239 |
UniProt ID: | O15265 |
HUGO ID: | 10560 |
Reference SNp(RefSNP): | rs193922929 |
Disease/Mutation information |
Target Mutation: | c.88_90CAG(7_17)
|
Matation type/variant: | Microsatellite
|
Mutation at gene level: | NG_008227.1:g.53130_53132CAG(7_17)
|
Pathogenic status of mutation: | Pathogenic
|
Disease: | Spino Cerebellar Ataxia type-7 (SCA-7) |
Clinical Resources |
ClinVar ID: | 2953 |
KEGG disease ID: | H00063 |
OMIM ID: | 164500 |
COSMIC: | ATXN7 |
DECIPHER: | ATXN7 |
GeneTests: | ATXN7 |
ASP siRNA details |
Mutant allele (5'->3'): | CAGCCAUGAACAAUGUCCA
|
ASP-siRNA (As strand 3'->5'): | GUCGGUACUUGUUACAGGU
|
Percentage efficacy of ASP-siRNA for mutant allele: | NA
|
Wild allele (5'->3'): | CAGCCGUGAACAAUGUCCA
|
ASP-siRNA (As strand 3'->5'): | GUCGGUACUUGUUACAGGU
|
Percentage efficacy of ASP-siRNA for wild allele: | 10
|
Relative difference: | NA
|
Wild siRNA details |
Wild allele (5'->3'): | CAGCCGUGAACAAUGUCCA
|
Wild siRNA (As strand 3'->5'): | GUCGGCACUUGUUACAGGU
|
Percentage efficacy of wild siRNA for wild allele: | 49
|
Wild allele (5'->3'): | CAGCCGUGAACAAUGUCCA
|
ASP-siRNA (As strand 3'->5'): | GUCGGUACUUGUUACAGGU
|
Percentage efficacy of Wild sirna for mutant allele: | 20
|
Relative difference : | 29
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | HEK293 |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Constructed by PCR |
Post-transfection duration: | 48 hours |
Concentration used: | 50nM |
Reference: | 19789634 |
Delivery method: | Transfection |
'Article title: | Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype. |
'Authors: | Scholefield J, Greenberg LJ, Weinberg MS, Arbuthnot PB, Abdelgany A, Wood MJ. |
'Journal Reference: | PLoS One. 2009 Sep 30;4(9):e7232. doi: 10.1371/journal.pone.0007232. |
'